Stay updated on Nivolumab and Plinabulin in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Plinabulin in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Plinabulin in NSCLC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2. The page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-20T08:19:47.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov site revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-13T07:58:59.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error with the 403 header and navigation elements (including Home and a Revision: v3.7.0 line). A large set of study-related terms and identifiers was removed from the page content.
    Difference
    18%
    Check dated 2026-09-22T06:33:32.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Revision: v3.6.6 appears as the new page revision tag, replacing Revision: v3.6.5. This is a minor release update to the page and does not modify the displayed study details.
    Difference
    0.1%
    Check dated 2026-08-31T23:30:47.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.4 to v3.6.5, indicating a minor update to the record display.
    Difference
    0.1%
    Check dated 2026-08-10T22:07:53.000Z thumbnail image
  7. Check
    88 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.3 to v3.6.4, reflecting a minor update to the study record metadata.
    Difference
    0.1%
    Check dated 2026-07-27T17:47:34.000Z thumbnail image

Stay in the know with updates to Nivolumab and Plinabulin in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Plinabulin in NSCLC Clinical Trial page.